These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry. Zhang H, Young SP, Millington DS. Curr Protoc; 2023 Mar; 3(3):e701. PubMed ID: 36929617 [Abstract] [Full Text] [Related]
5. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Khan SA, Mason RW, Giugliani R, Orii K, Fukao T, Suzuki Y, Yamaguchi S, Kobayashi H, Orii T, Tomatsu S. Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903 [Abstract] [Full Text] [Related]
6. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry. Tomatsu S, Montaño AM, Oguma T, Dung VC, Oikawa H, Gutiérrez ML, Yamaguchi S, Suzuki Y, Fukushi M, Barrera LA, Kida K, Kubota M, Orii T. Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038 [Abstract] [Full Text] [Related]
7. Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry. Zhang H, Young SP, Auray-Blais C, Orchard PJ, Tolar J, Millington DS. Clin Chem; 2011 Jul; 57(7):1005-12. PubMed ID: 21576268 [Abstract] [Full Text] [Related]
8. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III. de Ruijter J, de Ru MH, Wagemans T, Ijlst L, Lund AM, Orchard PJ, Schaefer GB, Wijburg FA, van Vlies N. Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433 [Abstract] [Full Text] [Related]
9. A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses. Chuang CK, Lin HY, Wang TJ, Tsai CC, Liu HL, Lin SP. Orphanet J Rare Dis; 2014 Sep 02; 9():135. PubMed ID: 25178307 [Abstract] [Full Text] [Related]
10. A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses. Langereis EJ, Wagemans T, Kulik W, Lefeber DJ, van Lenthe H, Oussoren E, van der Ploeg AT, Ruijter GJ, Wevers RA, Wijburg FA, van Vlies N. PLoS One; 2015 Sep 02; 10(9):e0138622. PubMed ID: 26406883 [Abstract] [Full Text] [Related]
11. Newborn screening and diagnosis of mucopolysaccharidoses. Tomatsu S, Fujii T, Fukushi M, Oguma T, Shimada T, Maeda M, Kida K, Shibata Y, Futatsumori H, Montaño AM, Mason RW, Yamaguchi S, Suzuki Y, Orii T. Mol Genet Metab; 2013 Sep 02; 110(1-2):42-53. PubMed ID: 23860310 [Abstract] [Full Text] [Related]
12. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses. Kubaski F, Suzuki Y, Orii K, Giugliani R, Church HJ, Mason RW, Dũng VC, Ngoc CT, Yamaguchi S, Kobayashi H, Girisha KM, Fukao T, Orii T, Tomatsu S. Mol Genet Metab; 2017 Mar 02; 120(3):247-254. PubMed ID: 28065440 [Abstract] [Full Text] [Related]
13. Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis. Lin HY, Lo YT, Wang TJ, Huang SF, Tu RY, Chen TL, Lin SP, Chuang CK. Sci Rep; 2019 Jul 24; 9(1):10755. PubMed ID: 31341247 [Abstract] [Full Text] [Related]
14. UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses. Auray-Blais C, Lavoie P, Tomatsu S, Valayannopoulos V, Mitchell JJ, Raiman J, Beaudoin M, Maranda B, Clarke JT. Anal Chim Acta; 2016 Sep 14; 936():139-48. PubMed ID: 27566349 [Abstract] [Full Text] [Related]
15. Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses. Volpi N, Maccari F, Galeotti F, Zampini L, Santoro L, Padella L, Galeazzi T, Gabrielli O, Coppa GV. J Pharm Biomed Anal; 2013 Nov 14; 85():40-5. PubMed ID: 23872470 [Abstract] [Full Text] [Related]
16. Quantitative analysis of glycosaminoglycans, chondroitin/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography-electrospray ionization-tandem mass spectrometry. Osago H, Shibata T, Hara N, Kuwata S, Kono M, Uchio Y, Tsuchiya M. Anal Biochem; 2014 Dec 15; 467():62-74. PubMed ID: 25197028 [Abstract] [Full Text] [Related]
17. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry. Kubaski F, Mason RW, Nakatomi A, Shintaku H, Xie L, van Vlies NN, Church H, Giugliani R, Kobayashi H, Yamaguchi S, Suzuki Y, Orii T, Fukao T, Montaño AM, Tomatsu S. J Inherit Metab Dis; 2017 Jan 15; 40(1):151-158. PubMed ID: 27718145 [Abstract] [Full Text] [Related]
18. Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapy. Zhang H, Dickson PI, Stiles AR, Chen AH, Le SQ, McCaw P, Beasley J, Millington DS, Young SP. Clin Chim Acta; 2020 Sep 15; 508():179-184. PubMed ID: 32442432 [Abstract] [Full Text] [Related]
19. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses. Shimada T, Kelly J, LaMarr WA, van Vlies N, Yasuda E, Mason RW, Mackenzie W, Kubaski F, Giugliani R, Chinen Y, Yamaguchi S, Suzuki Y, Orii KE, Fukao T, Orii T, Tomatsu S. Mol Genet Metab; 2014 Sep 15; 113(1-2):92-9. PubMed ID: 25092413 [Abstract] [Full Text] [Related]
20. The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses. Lin HY, Lee CL, Lo YT, Wang TJ, Huang SF, Chen TL, Wang YS, Niu DM, Chuang CK, Lin SP. Mol Genet Genomic Med; 2018 Nov 15; 6(6):982-992. PubMed ID: 30296009 [Abstract] [Full Text] [Related] Page: [Next] [New Search]